View Clinical Trial (Medical Research Study)
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis - NCT01081782-32174(Clinical Trial 567025)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Ormond Beach |
|
State:
|
|
FL |
| Zip Code: |
|
32174 |
| Conditions: |
|
Multiple Sclerosis |
| Purpose: |
|
The objective of this study is to evaluate the safety and efficacy of ONO-4641 in patients
with relapsing-remitting multiple sclerosis over a 26-week treatment period.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Adult male or female aged 18-55 years inclusive at screening
- Patients who have a definite diagnosis of relapsing-remitting Multiple Sclerosis
Exclusion Criteria:
- Multiple Sclerosis course other than relapsing-remitting multiple sclerosis
- History of malignancy
- History of clinically significant chronic disease of the immune system (other than
Multiple Sclerosis)
- Inability to undergo Gd-enhanced MRI scans
- Diagnosis of diabetes mellitus (type I or type II) |
|
|
|
| Study is available at: |
|
Ormond Beach Clinical Site 129
Ormond Beach, FL 32174
United States
Primary Contact:
Brenda Souza
Phone: (609) 512-4129 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|